{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thrombomodulin-related-bleeding-disorder","columns":[{"gene":"","key":"population-503360774246aa36e383","label":"Thrombophilia due to thrombomodulin defect","mondoId":"MONDO:0013775","onsetQualifier":null,"originColumnKey":"MONDO:0013775/OMIM:614486","originalViews":[{"key":"MONDO:0013775/OMIM:614486","label":"Thrombophilia due to thrombomodulin defect","scopeLabel":"OMIM:614486","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["4283cf6f2cf439fb5e0932920ff05c8754a35589bde6a797cc0305c9b50acbf8","49ee52c15dbc174307eccd4c62fefaa37510ae3688bfa08415e693390e525830","7ca10da24f8071f38db0de585a4368824d52607cf15a37edef5a0c1bf520605d"],"recordQualifiers":{},"scopeLabel":"OMIM:614486","sourceIds":["OMIM:614486"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-503360774246aa36e383"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002625","HP:0100724","HP:0002204"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"published":3}},"features":[{"hpoId":"HP:0002625","label":"Deep venous thrombosis","primary":true},{"hpoId":"HP:0100724","label":"Hypercoagulability","primary":true},{"hpoId":"HP:0002204","label":"Pulmonary embolism","primary":true}],"ledeHtml":"A rare genetic coagulation disorder characterized by marked bleeding tendency and posttraumatic bleeding with easy bruising, soft tissue and muscle bleeding, hemarthroses, and menorrhagia due to an increase of soluble thrombomodulin in plasma with subsequent protein C activation and reduction of thrombin generation within a potential thrombus. Abnormal laboratory findings include markedly elevated plasma thrombomodulin, reduced prothrombin consumption, and decreased thrombin generation.","mondoId":"MONDO:0013775","node":{"canonicalSlug":"thrombomodulin-related-bleeding-disorder","comparisons":[{"documentSha256":"547bce4f03975dd18600dfa9f3c1cb21856a19c592d867e5ac6798b6db63ee32","key":"legacy-thrombomodulin-related-bleeding-disorder","kind":"legacy","label":"thrombomodulin-related bleeding disorder","memberIds":["MONDO:0013775"],"mondoId":"MONDO:0013775","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/thrombomodulin-related-bleeding-disorder.547bce4f03975dd18600dfa9f3c1cb21856a19c592d867e5ac6798b6db63ee32.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Thrombomodulin-related bleeding disorder","originalSourceId":"ORPHA:436169","paragraphs":["A rare genetic coagulation disorder characterized by marked bleeding tendency and posttraumatic bleeding with easy bruising, soft tissue and muscle bleeding, hemarthroses, and menorrhagia due to an increase of soluble thrombomodulin in plasma with subsequent protein C activation and reduction of thrombin generation within a potential thrombus. Abnormal laboratory findings include markedly elevated plasma thrombomodulin, reduced prothrombin consumption, and decreased thrombin generation."],"rawAttribution":"ORPHA:436169","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:49Z","upstream":"ORPHA:436169","url":"https://rarediseases.info.nih.gov/diseases/17726"},"ownColumnKeys":["population-503360774246aa36e383"],"publication":"published","relationships":[{"kind":"parent","label":"coagulation protein disease","mondoId":"MONDO:0002242","slug":"coagulation-protein-disease"},{"kind":"parent","label":"hemorrhagic disease","mondoId":"MONDO:0002243","slug":null},{"kind":"parent","label":"inherited thrombophilia","mondoId":"MONDO:0100240","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"4283cf6f2cf439fb5e0932920ff05c8754a35589bde6a797cc0305c9b50acbf8","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614486","disease_name":"Thrombophilia due to thrombomodulin defect","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002625","is_excluded":false,"label":"Deep venous thrombosis","onset_id":null,"reference":"PMID:7811989","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"49ee52c15dbc174307eccd4c62fefaa37510ae3688bfa08415e693390e525830","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614486","disease_name":"Thrombophilia due to thrombomodulin defect","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100724","is_excluded":false,"label":"Hypercoagulability","onset_id":null,"reference":"PMID:7811989","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7ca10da24f8071f38db0de585a4368824d52607cf15a37edef5a0c1bf520605d","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:614486","disease_name":"Thrombophilia due to thrombomodulin defect","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002204","is_excluded":false,"label":"Pulmonary embolism","onset_id":null,"reference":"PMID:7811989","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17726\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:436169</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic coagulation disorder characterized by marked bleeding tendency and posttraumatic bleeding with easy bruising, soft tissue and muscle bleeding, hemarthroses, and menorrhagia due to an increase of soluble thrombomodulin in plasma with subsequent protein C activation and reduction of thrombin generation within a potential thrombus. Abnormal laboratory findings include markedly elevated plasma thrombomodulin, reduced prothrombin consumption, and decreased thrombin generation.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17726\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"thrombomodulin-related-bleeding-disorder","sourceDocuments":[{"name":"GARD: Thrombomodulin-related bleeding disorder","reviewed":null,"source_release":"2026-10-21T17:02:49Z","url":"https://rarediseases.info.nih.gov/diseases/17726"}],"sourceNote":"","synonyms":["THBD-related bleeding disorder","THBD-related coagulopathy","THPH12","thrombomodulin-related coagulopathy","thrombophilia 12 due to thrombomodulin defect","thrombophilia due to thrombomodulin defect"],"takeawayHtml":"","title":"thrombomodulin-related bleeding disorder"},"schemaVersion":1}
